Valuation: Coloplast A/S

Capitalization 91.03B 14.13B 12.18B 11.16B 10.55B 19.44B 1,368B 19.93B 133B 51.8B 644B 53.01B 51.88B 2,248B P/E ratio 2026 *
29.2x
P/E ratio 2027 * 15.2x
Enterprise value 112B 17.38B 14.99B 13.73B 12.97B 23.92B 1,682B 24.52B 164B 63.71B 792B 65.21B 63.82B 2,765B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.61x
Free-Float
63.42%
Yield 2026 *
5.02%
Yield 2027 * 5.49%
1 day+0.02%
1 week+0.97%
Current month+2.67%
1 month-9.83%
3 months-16.53%
6 months-29.96%
Current year-25.99%
1 week 390
Extreme 390
408
1 month 390
Extreme 390
443
Current year 390
Extreme 390
584.2
1 year 390
Extreme 390
651.8
3 years 390
Extreme 390
977.6
5 years 390
Extreme 390
1,194
10 years 390
Extreme 390
1,194
Manager TitleAgeSince
Chief Executive Officer 67 04/05/2025
Director of Finance/CFO 54 31/12/2005
Chief Operating Officer 59 04/09/2008
Director TitleAgeSince
Director/Board Member 78 12/12/2006
Director/Board Member 55 17/09/2009
Chairman 57 04/05/2025
Change 5d. change 1-year change 3-years change Capi.($)
+0.02%+0.97%-37.24%-55.70% 14.18B
-1.70%-2.53%+118.17%+111.40% 4.88B
+1.04%+1.57%+370.17%+177.18% 3.64B
-0.63%-6.16%-39.48%-28.95% 2.6B
-0.29%-3.37%-41.89%-72.08% 1.99B
0.00%-5.26%-4.71%-30.77% 1.63B
-0.16%-3.76%-36.00%-52.24% 1.11B
+0.18%-11.76%+30.06%+0.36% 1.02B
0.00%+10.98%+22.97%+54.24% 1.05B
-0.40%-1.25%+32.03%-9.15% 944M
Average -0.19%-1.84%+41.41%+9.43% 3.31B
Weighted average by Cap. -0.21%-0.36%+37.72%+3.65%

Financials

2026 *2027 *
Net sales 28.74B 4.46B 3.85B 3.52B 3.33B 6.14B 432B 6.29B 42B 16.35B 203B 16.74B 16.38B 710B 30.73B 4.77B 4.11B 3.77B 3.56B 6.56B 462B 6.73B 44.9B 17.49B 217B 17.9B 17.51B 759B
Net income 3.15B 488M 421M 386M 365M 672M 47.27B 689M 4.6B 1.79B 22.25B 1.83B 1.79B 77.71B 5.98B 928M 801M 733M 693M 1.28B 89.87B 1.31B 8.74B 3.4B 42.31B 3.48B 3.41B 148B
Net Debt 20.94B 3.25B 2.8B 2.57B 2.43B 4.47B 315B 4.59B 30.6B 11.92B 148B 12.19B 11.93B 517B 20.02B 3.11B 2.68B 2.45B 2.32B 4.28B 301B 4.38B 29.25B 11.39B 142B 11.66B 11.41B 494B
Logo Coloplast A/S
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
17,083
Date Price Change Volume
19/05/26 404.40 kr +0.02% 400,094
18/05/26 404.30 kr +1.25% 702,342
13/05/26 399.30 kr -1.92% 361,846
12/05/26 407.10 kr +1.65% 340,510
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
404.30DKK
Average target price
460.90DKK
Spread / Average Target
+14.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. COLO B Stock